Literature DB >> 19891007

Plasmid-free T7-based Escherichia coli expression systems.

Gerald Striedner1, Irene Pfaffenzeller, Luchner Markus, Sabine Nemecek, Reingard Grabherr, Karl Bayer.   

Abstract

In order to release host cells from plasmid-mediated increases in metabolic load and high gene dosages, we developed a plasmid-free, T7-based E. coli expression system in which the target gene is site-specifically integrated into the genome of the host. With this system, plasmid-loss, a source of instability for conventional expression systems, was eliminated. At the same time, system leakiness, a challenging problem with recombinant systems, was minimized. The efficiency of the T7 RNA polymerase compensates for low gene dosage and provides high rates of recombinant gene expression without fatal consequences to host metabolism. Relative to conventional pET systems, this system permits improved process stability and increases the host cell's capacity for recombinant gene expression, resulting in higher product yields. The stability of the plasmid-free system was proven in chemostat cultivation for 40 generations in a non-induced and for 10 generations in a fully induced state. For this reason plasmid-free systems benefit the development of continuous production processes with E. coli. However, time and effort of the more complex cloning procedure have to be considered in relation to the advantages of plasmid-free systems in upstream-processing. (c) 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19891007     DOI: 10.1002/bit.22598

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  16 in total

1.  Coupling the CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified Chromosomal Gene Replacement in Escherichia coli.

Authors:  Michael E Pyne; Murray Moo-Young; Duane A Chung; C Perry Chou
Journal:  Appl Environ Microbiol       Date:  2015-05-22       Impact factor: 4.792

Review 2.  Antibiotic-free selection in biotherapeutics: now and forever.

Authors:  Charlotte Mignon; Régis Sodoyer; Bettina Werle
Journal:  Pathogens       Date:  2015-04-03

3.  Comparative transcription profiling and in-depth characterization of plasmid-based and plasmid-free Escherichia coli expression systems under production conditions.

Authors:  Juergen Mairhofer; Theresa Scharl; Karoline Marisch; Monika Cserjan-Puschmann; Gerald Striedner
Journal:  Appl Environ Microbiol       Date:  2013-04-12       Impact factor: 4.792

4.  Exchange of single amino acids at different positions of a recombinant protein affects metabolic burden in Escherichia coli.

Authors:  Natalie Rahmen; Alexander Fulton; Nina Ihling; Marzio Magni; Karl-Erich Jaeger; Jochen Büchs
Journal:  Microb Cell Fact       Date:  2015-01-23       Impact factor: 5.328

5.  A comparative analysis of industrial Escherichia coli K-12 and B strains in high-glucose batch cultivations on process-, transcriptome- and proteome level.

Authors:  Karoline Marisch; Karl Bayer; Theresa Scharl; Juergen Mairhofer; Peter M Krempl; Karin Hummel; Ebrahim Razzazi-Fazeli; Gerald Striedner
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

6.  Repetitive genomic insertion of gene-sized dsDNAs by targeting the promoter region of a counter-selectable marker.

Authors:  Jaehwan Jeong; Han Na Seo; Yu Kyung Jung; Jeewon Lee; Gyuri Ryu; Wookjae Lee; Euijin Kwon; Keunsoo Ryoo; Jungyeon Kim; Hwa-Young Cho; Kwang Myung Cho; Jin Hwan Park; Duhee Bang
Journal:  Sci Rep       Date:  2015-03-04       Impact factor: 4.379

7.  Evaluation of three industrial Escherichia coli strains in fed-batch cultivations during high-level SOD protein production.

Authors:  Karoline Marisch; Karl Bayer; Monika Cserjan-Puschmann; Markus Luchner; Gerald Striedner
Journal:  Microb Cell Fact       Date:  2013-06-11       Impact factor: 5.328

8.  Strong stimulation of recombinant protein production in Escherichia coli by combining stimulatory control elements in an expression cassette.

Authors:  Friederike Zwick; Rahmi Lale; Svein Valla
Journal:  Microb Cell Fact       Date:  2012-10-02       Impact factor: 5.328

9.  Fed-batch like cultivation in a micro-bioreactor: screening conditions relevant for Escherichia coli based production processes.

Authors:  Csilla Toeroek; Monika Cserjan-Puschmann; Karl Bayer; Gerald Striedner
Journal:  Springerplus       Date:  2015-09-11

Review 10.  Microbials for the production of monoclonal antibodies and antibody fragments.

Authors:  Oliver Spadiut; Simona Capone; Florian Krainer; Anton Glieder; Christoph Herwig
Journal:  Trends Biotechnol       Date:  2013-10-31       Impact factor: 19.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.